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Abstract
Aberrant stimulation of the canonical Wnt pathway induces mammary tumorigenesis in mice. It has been well
documented that two types of tumors, adenocarcinoma and adenocarcinoma with squamous metaplasia, develop
in these mutants. However, the molecular mechanism underlying the induction of squamous transdifferentiation
remains largely unknown. Here, we show that JNK/SAPK signaling plays an important role in Wnt-dependent mam-
mary development and malignant transformation. The JNK/SAPK pathway is stimulated in pregnancy-mediated
lobulo-alveolar morphogenesis, a process highly dependent on Wnt/β-catenin signaling. Strong elevations of
JNK/SAPK signaling are associated with squamous metaplasia of the Wnt-induced adenocarcinoma. Reconstitu-
tion of β-catenin and JNK/SAPK signaling activities also promotes expression of the squamous cell marker in cul-
tured epithelial cells. Furthermore, a synergistic activation of these two pathways can be identified in the malignant
squamous cells of human endometrial and lung cancers. This is potentially a significant discovery in modern cancer
therapy because of the effectiveness of an angiogenesis inhibitor, Avastin, for the treatment of adenocarcinoma, but
not squamous cell carcinoma, in human lung cancers. Our finding may improve the usage of biomarkers to distin-
guish these two poorly differentiated tumor types, sharing similar histologic features.
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Introduction
Wnt signaling is important for diverse processes during embryonic,
fetal, and postnatal development [1]. Deregulation of Wnt signaling
has also been linked to pathogenesis of various diseases [2]. β-Catenin,
a key component of adherens junction, plays an essential role in trans-
duction of the canonical Wnt pathway [3]. The cellular level of β-
catenin is controlled by a disruption complex, including Axin, APC,
and GSK-3β [4]. In the absence of a Wnt signal, this complex binds
to β-catenin, mediating its phosphorylation and degradation through
the ubiquitin-mediated proteolysis system [5]. Wnt signals perturb
the formation of the disruption complex by activating the upstream
regulators, leading to nuclear accumulations of β-catenin [6]. The
downstream signaling events are triggered by its interaction with tran-
scription factors of the lymphoid enhancer factor/T cell factor (LEF/
TCF) family to regulate target gene expression [7].
Wnt signaling is intimately involved in the development and neo-
plastic transformation of the mammary gland [8]. Several members
of the Wnt family are expressed in the epithelium and stromal
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compartments at various stages of mammary development [9]. It
has been well established that aberrant stimulation of the canonical
Wnt pathway, such as transgenic expression of Wnt1, Wnt10b, re-
sults in mammary tumorigenesis in mice [10,11]. Expression of a
degradation-deficient form of β-catenin leads to the formation of
mammary tumors in mice [12]. Transgenic mice with elevated levels
of the Wnt target cyclin D1 or c-myc also develop mammary tumors
[13,14]. Furthermore, Wnt signals are required not only for induc-
tion but also for the inhibition of mammary development. The loss
of Wnt4 impairs the early phases of pregnancy-dependent mammary
morphogenesis [15]. In contrast, Wnt5a-null mammary tissue ex-
hibits an accelerated cell growth and proliferation capacity [16]. This
probably is due to the involvement of Wnt5a in an alternative path-
way (see below). Reduction of Wnt/β-catenin signaling by high levels
of Axin or a dominant-negative β-catenin interferes with alveolar
morphogenesis at late pregnancy stages [17,18]. The loss of LEF-1
transcription factor in mice led to the lack of mammary bud forma-
tion at embryogenesis [19]. These studies imply that Wnt signaling
is critical for mammary development in health and disease.
In addition to β-catenin, Wnt signals have been shown to trans-
duce through alternative pathways [20,21]. Wnt5a, Wnt5b, and
Wnt11 are representatives of noncanonical Wnt signaling through
JNK/SAPK (Jun N-terminal kinase/stress–activated protein kinase),
a cascade similar to the planer cell polarity pathway in Drosophila.
Aberrant activation of Wnt/JNK pathway seems to develop more
malignant phenotypes, such as abnormal tissue polarity, invasion,
and metastasis [21]. Stimulation of Wnt5a has been associated with
various types of human cancers, including gastric cancer, lung can-
cer, and melanoma. There are a few molecules playing an essential
role in both canonical and noncanonical pathways, suggesting that
the Wnt signal might diverge at these transducers. Both Dsh/Dvl
and Axin have been shown to activate Wnt/JNK signaling cascade
through domains distinct from those regulating β-catenin [22]. Axin
induces JNK/SAPK activity through its MEKK1 binding and self-
association domains [23]. These domains do not seem to be required
for down-regulation of β-catenin in Xenopus axis determination [24].
In Drosophila, the DIX domain of Dsh is dispensable for the planer
cell polarity pathway, whereas it is essential for β-catenin signaling
[25]. The dual role of signal transducers raises the question of overlap
between the Wnt pathways, as well as other signaling pathways.
However, the significance of cross-signaling interaction in normal de-
velopmental processes and pathogenesis of human diseases remains
largely elusive.
In this study, we investigated the potential role of JNK/SAPK sig-
naling in Wnt-dependent mammary development and tumorigenesis
in mice. The JNK and its related p38 MAP kinases were stimulated
during pregnancy-mediated lobulo-alveolar morphogenesis, a process
highly dependent on Wnt/β-catenin signaling. In the hyperplasia and
adenocarcinoma caused by high levels of Wnt, JNK/SAPK signaling
apparently was not induced. However, the Wnt/JNK pathway was
strongly stimulated in squamous metaplasia, a process in which the
presence of glandular epithelium is replaced by squamous epithe-
lium, suggesting its involvement in the transdifferentiation of ma-
lignant cells. Reconstitution of β-catenin and JNK/SAPK signaling
activities promoted expression of squamous cell markers in cultured
epithelial cells. Furthermore, our finding led us to identify that these
two pathways are synergistically activated in the malignant squamous
cells of human endometrial and lung cancers. Our results suggest that
JNK/SAPK signaling not only has a crucial function in squamous cell
differentiation but also plays a co-opted role in the Wnt/β-catenin–
mediated oncogenic transformation.
Materials and Methods
Animals and Human Samples
MMTV-Wnt1mice, expressingWnt1 under control of theMMTV
promoter, were generated and described previously [26]. Briefly, mam-
mary hyperplasia could be detected in all of the transgenic animals.
Approximately 50% of the females developed mammary tumor at 3
to 6 months of age. Mice carrying the MMTV-Wnt1 transgene were
genotyped by polymerase chain reaction analysis using primers (5′-
ggacttgcttctcttctcatagcc-3′ and 5′-ccacacaggcatagagtgtctgc-3′) to iden-
tify the transgene. The polymerase chain reaction was performed by
denaturation at 94°C for 2 minutes and 34 cycles of amplification
(94°C for 30 seconds, 60°C for 30 seconds, and 72°C for 45 seconds),
followed by a 2-minute extension at 72°C. Care and use of experimen-
tal animals described in this work comply with guidelines and policies
of the University Committee on Animal Resources at the University of
Rochester. The paraffin sections of human endometrial and lung
cancers were obtained based on a protocol approved by University
of Rochester Research Subjects Review Board. The identifiers of all
patients have been removed to protect confidentiality. The study, ap-
proved by the program director at the National Cancer Institute, was
judged “NO” for human subject research because we could not have
an intervention with a living person and would not receive or record
any identifiable information.
Cells and DNA
C57MG and C57MG-Wnt1 mammary epithelial cell lines were
obtained from Arnold Levine [27]. Cells were cultured with DMEM
containing 10% FCS, 100 U of penicillin, and 100 mg/ml strepto-
mycin in a humidified 5% CO2 incubator at 37°C. The pcatC-Lef1
is a DNA plasmid containing the C-terminal activation domain of
human β-catenin (amino acids 696-781) fused to the amino ter-
minus of LEF-1 [28]. The pCMV-ΔMEKK1 contains a dominant/
constitutively active form of MEKK1 under control of a CMV pro-
moter [29]. The pCMV-SEKED is a plasmid permitting the expres-
sion of a partially active SEK1 [30]. Approximately 2 × 104 cells were
plated 24 hours before transfection. Introduction of DNA plasmids
(0.5 μg per plasmid) into the cultured cells was performed by
Lipofectamine 2000–mediated transfection according to the manu-
facturer’s protocol (Invitrogen, Carlsbad, CA). Cells were harvested
24 hours after the transfection.
Histologic Diagnosis, Immunostaining, and Immunoblot
Samples were fixed, paraffin-embedded, sectioned, and stained with
hematoxylin/eosin for histologic evaluation as described [31,32].
Tissue sections were subject to immunologic staining with avidin/
biotinlylated enzyme complex or indirect fluorescent staining as de-
scribed [17,33,34]. Briefly, samples were deparaffinized and hydrated,
followed by antigen unmasking (Vector Laboratories, Burlingame,
CA). Endogenous peroxidase activity was blocked by incubating
sections with 3% hydrogen peroxide. For the use of mouse primary
antibodies, sections were incubated with mouse IgG blocking solu-
tion (Vector Laboratories). After addition of primary antibodies for
30 minutes at room temperature, sections were incubated with horse-
radish peroxidase–conjugated secondary antibodies for 10 minutes at
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room temperature. The staining was then visualized by enzymatic
color reaction according to the manufacturer’s specification (Vector
Laboratories). Images were analyzed using an Axio Observer micro-
scope and a SPOT-RT camera (Carl Zeiss, Thornwood, NY). For
immunoblot analysis, cells were lysed with M-PER reagent (78501;
Pierce, Rockford, IL), containing protease inhibitor cocktail (diluted
at 1:100, P8340; Sigma, St. Louis, MO), for 5 minutes with gentle
shaking. Cell lysates were subject to immunoblot analysis as described
[35,36]. Bound primary antibodies were detected with horseradish
peroxidase–conjugated secondary antibodies, followed by enhanced
chemical luminescence-mediated visualization (Amersham, Piscataway,
NJ) and autoradiography. Mouse monoclonal antibodies actin (Lab
Vision, Fremont, CA), ABC (Upstate, Billerica, MA), and HMW-
Keratin (Lab Vision); rabbit polyclonal antibodies cyclin D1 (Lab
Vision), β-catenin (Lab Vision), PJNK (Cell Signaling, Danvers, MA),
Pp38 (Cell Signaling), PErk1/2 (Cell Signaling), PJun63 (Cell Signal-
ing), and PJun73 (Cell Signaling) were used as primary antibodies.
Results
JNK/SAPK Signaling in Mammary Development
To investigate the involvement of JNK/SAPK signaling in mam-
mary development, we examined the expression of phosphorylated
forms of JNK/SAPK signaling molecules. Immunostaining of phos-
phorylated JNK (PJNK) did not show its presence in nulliparous
glands at 3 months (Figure 1A). Because JNK/SAPK belongs to
the mitogen-activated protein kinase (MAPK) family, we therefore
tested the activity of the other two signaling cascades. Phosphoryla-
tion of a closely related p38 MAP kinase (Pp38), which is also acti-
vated by a variety of cellular stresses, was not detected (Figure 1B).
However, the expression of PJNK and Pp38 was highly stimulated in
mammary epithelial cells undergoing pregnancy-dependent alveolar
development (Figure 1, F and G ). In contrast, phosphorylated
Erk1/2 (PErk1/2), a third member of the MAPK family, was present
in both nulliparous and parous glands (Figure 1, C and H ). The
stimulation of PJNK and Pp38 were accompanied by enhanced
phosphorylation of c-Jun at Ser63 (PJun63) and Ser73 (PJun73) in
the luminal epithelia (Figure 1, D, E , I , and J ). Although PJun73
could be found in few cells before the pregnancy-mediated differen-
tiation of lobulo-alveoli, the results were consistent with a drastic
stimulation of JNK/SAPK signaling, suggesting its involvement in
mammary development.
Stimulation of JNK/SAPK Signaling in Squamous Metaplasia
We next determined whether JNK/SAPK signaling plays a role in
Wnt-induced mammary tumorigenesis by examining MMTV-Wnt1
mice, in which Wnt1 is expressed constitutively under control of the
mouse mammary tumor virus (MMTV) promoter. Consistent with
the importance of β-catenin–mediated malignant transformation,
β-catenin became nuclearly localized in the hyperplastic epithelia,
before the onset of tumorigenesis, induced by MMTV-Wnt1 (Fig-
ure 2G ). Meanwhile, only membrane staining of β-catenin was dis-
played in the control littermate (Figure 2A). However, JNK/SAPK
signaling was not affected by the constitutive expression of Wnt1
in the hyperplastic stage (Figure 2). The phosphorylated JNK, p38,
and c-Jun63 were not detected in both the MMTV-Wnt1 and the
control mice (Figure 2, B, C , E , H , I , and K ). The MMTV-Wnt1
transgene also had no effects on the expression of PErk1/2 at a low
level, and the expression of PJun73 was noticeable in few cells, in both
the normal and hyperplastic mammary glands (Figure 2, D, F, J , and
L). Overall, there were no significant differences in the expression of
PJNK, Pp38, PErk1/2, PJun63, and PJun73 between the MMTV-
Wnt1 and control mice. The stress-induced signaling, including that
of JNK/SAPK and p38 MAPK, was not affected in hyperplasia in-
duced by high levels of Wnt/β-catenin signaling.
In MMTV-Wnt1 mice, two types of mammary tumors, adenocar-
cinoma (AC) and adenocarcinoma with squamous metaplasia (SM),
were identified usually after 3 months (Figure 3, A and I ). Immuno-
staining of high–molecular weight keratin (HMW-K), a marker for
squamous cells, revealed a relatively high percentage of the Wnt-
induced tumors undergoing squamous differentiation (62.5%, n =
8; Figure 3, H and P). We then examined the activity of Wnt/β-
catenin and JNK/SAPK signaling in AC and SM. Consistent with
Figure 1. The involvement of JNK/SAPK signaling in mammary gland development. Sections of mouse virgin gland (A–E) and mammary
gland undergoing pregnancy-dependent morphogenesis (F–J) were analyzed by immunochemical staining for phosphorylated JNK
(PJNK; A, F), phosphorylated p38 (Pp38; B, G), and phosphorylated Erk1/2 (PErk1/2; C, H), phosphorylated c-Jun at Ser63 (PJun63;
D, I) and phosphorylated c-Jun at Ser73 (PJun73; E, J). In the virgin gland, mammary epithelia showed that PErk1/2 is highly expressed
and PJun73 is positive for a few cells. In contrast, all JNK/SAPK signaling molecules were strongly activated during pregnancy-mediated
mammary development. The immunochemistry (brown)–stained sections were counterstained with hematoxylin (blue). The experi-
ments were performed in three different wild type and transgenic animals (n = 3). Scale bar, 100 μm (A–J).
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previous findings, the expressions of β-catenin and its direct down-
stream gene cyclin D1 [37,38] were elevated in both AC and SM (Fig-
ure 3, B, C , J and K ; n = 8), supporting the notion that transgenic
expression of a stabilized form of β-catenin or cyclin D1 in the mouse
mammary epithelia developed both types of tumor [13,39]. Squamous
differentiation is often observed in the Wnt-induced tumorigenesis.
To further elucidate the mechanism underlying Wnt-mediated on-
cogenic transformation, we studied whether the activation of JNK/
SAPK signaling is associated with this process. Similar to what was
observed in the Wnt-induced hyperplasia, the expression of PJNK,
Pp38 and PJun73 also was not detected in AC (Figure 3, D, E , and
G ). PErk1/2 was detected in both AC and SM (Figure 3, F and N ).
However, PJNK, Pp38, and PJun73 were highly stimulated in SM
(Figure 3, L, M , and O; n = 5). These data demonstrated that stress
signaling was dramatically enhanced in the Wnt-induced malignant
cells undergoing squamous differentiation. This raises the possibility
that synergistic activation of these two signaling cascades might be
involved in the metaplastic transformation.
Molecular Mechanism of JNK/SAPK Activation
To examine whether activation of Wnt/β-catenin signaling has any
effects on JNK/SAPK signaling, a dominant-negative form of Axin
(dnAxin) and a fusion protein of β-catenin and LEF1 (catCLEF1)
were used to induce this signaling pathway. The catCLEF1 protein
is a chimera, which links the C-terminal activation domain of human
β-catenin to the N-terminus of LEF-1 and constitutively induces tran-
scription of downstream genes [28]. In cells expressing catCLEF1, we
detected a higher–molecular weight protein, presumably the chimera,
using an antibody recognizing a nonphosphorylated/stabilized form
of β-catenin (Figure 4A). This was accompanied by a slight elevation
of cyclin D1, but no alteration in the expression of PJNK, Pp38,
PJun63, and PJun73 was observed in these catCLEF1-expressing cells
(Figure 4A). We previously demonstrated that expression of dnAxin,
which lacks the RGS/APC–binding domain, is able to induce axis du-
plication through stimulation of Wnt/β-catenin signaling [40]. A pre-
vious report also showed that deletion of the APC-binding domain of
Axin did not interfere with its ability to activate JNK/SAPK in a c-Jun
kinase assay in vitro [23]. Consistent with the previous finding, we
detected an increased level of the stabilized β-catenin (sβ-cat) when
dnAxin was expressed (Figure 4A). This also led to a slight enhance-
ment of the cyclin D1 expression (Figure 4A). We next examined if
Axin could stimulate JNK/SAPK signaling because it was suggested
to diverge from the Wnt/β-catenin pathway at this level [23]. Al-
though Pp38 showed a significant elevation, the expression of dnAxin
was insufficient to induce the expression of PJNK, PJun63, and PJun73
(Figure 4A). The lack of JNK and c-Jun stimulation was not due to the
deletion of the RGS/APC-binding domain because similar results were
detected using a full-length Axin (data not shown). The results imply
that the signaling cascade induced by Axin alone may not be sufficient
to promote JNK/SAPK activation in transfected cells.
Figure 2. JNK/SAPK signaling is not induced in mammary hyperplasia caused by elevated levels of Wnt/β-catenin signaling. Sections of
the wild type (A–F) and hyperplastic (G–L) mammary glands caused by high levels of Wnt signaling were analyzed by immunochemistry
for the expression of β-catenin (β-cat; A, G), PJNK (B, H), Pp38 (C, I), PErk1/2 (D, J), PJun63 (E, K), and PJun73 (F, L). The insets in A and G
display magnified images revealing differential localization of β-catenin. The immunochemistry (brown)–stained sections were counter-
stained with hematoxylin (blue). The experiments were performed in four different wild type and transgenic animals (n = 4). Scale bars,
100 μm (A–I).
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We next investigated at which molecular level the signaling acti-
vation is required to stimulate both JNK and p38. Dominant forms
of MEKK1 (ΔMEKK1) and SEK1 (SEKED) were used to activate the
downstream signaling cascade. MEKK1 is an MAPKKK which turns
on JNK through activation of SEK1 (a MAPKK also known as
MKK4) [41,42]. The expression of dominant SEK1 had no signifi-
cant effects on the phosphorylation of JNK, and c-Jun at Ser63 and
Ser73, but slightly enhanced the phosphorylation of p38 (data not
shown). However, the phosphorylation of p38, JNK, and c-Jun at
Ser63 and Ser73 was strongly stimulated by the dominant MEKK1
(Figure 4A). Consistent with the immunostaining results, Erk1/2 ap-
parently was not involved in this signaling pathway (data not shown).
These data suggest that stimulation of the JNK/SAPK pathway,
which is critical for mammary development and tumorigenesis, needs
to be activated at the level of, or upstream of MEKK1.
On the basis of prior reports, this could be achieved by activation
of Axin. However, we failed to detect stimulation of JNK/SAPK sig-
naling by high levels of Axin. The result is contradictory to the pre-
vious observations, suggesting that activation of JNK/SAPK signaling
is at the level upstream of Axin. Alternatively, a second signal parallel
to the Wnt pathway may be required. We then examined if overex-
pression of Wnt is sufficient to stimulate JNK/SAPK signaling. In
cells transfected by Wnt1, we detected similar results to those ob-
served in the dnAxin-expressing cells (Figure 4B). High levels of
Wnt1 failed to induce the JNK/SAPK activity, supporting that a sec-
ond signal parallel to the Wnt pathway is necessary for the JNK/
SAPK induction. Similar signaling effects were also detected in cells
treated with LiCl to induce Wnt/β-catenin signaling (Figure 4B). Al-
though these data imply our model of parallel signaling, we do not
rule out the possibility that this second pathway is converged at other
Wnt signaling molecules.
Induction of Squamous Differentiation by Wnt/β-catenin and
JNK/SAPK Pathways
On the basis of the above discovery, we hypothesized that simul-
taneous stimulation of Wnt/β-catenin and stress signaling promotes
squamous differentiation of epithelial cells. We therefore used a cell
culture system, which is more amenable to reconstituting the mo-
lecular events. First, the C57MG mammary epithelial cell line was
examined for the status of Wnt/β-catenin and JNK/SAPK signal-
ing. The JNK/SAPK signaling activity was apparently detected in
C57MG cells as PJun73 was detected in every single cell whereas
PJun63 was positive in only a few cells (Figure 5, A and B). We
noticed that phosphorylation at Ser63 seems to be more tightly
Figure 3. Stimulation of JNK/SAPK signaling is linked to the Wnt/β-catenin–induced squamous metaplasia in mice. Sections of the
mammary tumors, adenocarcinoma (AC; A–H) and adenocarcinoma with squamous metaplasia (SM; I–P), induced by Wnt1 were ana-
lyzed by histology (A, I) and immunochemistry (B–H and J–P) for the expression of β-cat (B, J), cyclin D1 (cycD1; C, K), PJNK (D, L), Pp38
(E, M), and PErk1/2 (F, N), PJun73 (G, O), and high–molecule weight keratin (HMW-K; H, P). The immunochemistry (brown)–stained
sections were counterstained with hematoxylin (blue). Wnt signaling is stimulated in both AC and SM because β-catenin is nuclearly
localized and cyclin D1 is highly expressed in malignant cells (B–C and J–K). In contrast, JNK/SAPK signaling is exclusively elevated in
SM (D–G and L–O). Scale bars, 100 μm (A–P).
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controlled, similar to those observed in mammary development (Fig-
ure 1) and hyperplasia (Figure 2). Wnt/β-catenin was not stimulated
because there was very little, if any, accumulation of β-catenin found
in these cells (Figure 5, C and D). In addition, the expression of a
squamous cell marker HMW-K was not detectable (Figure 5E ). The
preexisting JNK/SAPK signaling activation at certain levels makes
C57MG a good system to test our theory. We then examined the
C57MGWnt1 cell line, a derivative of C57MG with constitutive ex-
pression of Wnt1 [27]. C57MGWnt1 cells expressed PJun63 and
PJun73 at levels comparable to those in the parental cell line (Fig-
ure 5, F and G ). Due to constitutive expression of Wnt1, strong nu-
clear accumulations of β-catenin were clearly exhibited in these cells
(Figure 5, H and I ). Therefore, in addition to JNK/SAPK, Wnt/β-
catenin signaling is also elevated in C57MGWnt1 cells. A significant
portion of C57MGWnt1 cells expressed HMW-K, a well-characterized
feature of squamous differentiation (Figure 5J ).
To further confirm that squamous differentiation is promoted by
a synergistic activation of both pathways, we transiently expressed
catCLEF1 and ΔMEKK1 to induce Wnt/β-catenin and JNK/SAPK
signaling, respectively. The catCLEF1 protein constitutively induces
transcription of the Wnt downstream genes [28] whereas ΔMEKK1
constitutively activates JNK/SAPK signaling [29]. High levels of
HMW-K were detected in the C57MG cells expressing catCLEF1
and ΔMEKK1, indicating squamous differentiation (Figure 5, K and
N ). Expression of either ΔMEKK1 (Figure 5L) or catCLEF1 (Fig-
ure 5M) slightly enhances the expression of HMW-K. The Wnt and
JNK/SAPK pathways act synergistically to induce squamous differen-
tiation. Next, we examine if inhibition of JNK signaling prevents squa-
mous differentiation. The addition of JNK inhibitor had no significant
effect on the expression of HMW-K in C57MGWnt1 cells (Figure 5,O
and P), suggesting that activation of JNK/SAPK is not the limiting
factor. It is conceivable that squamous differentiation is caused by the
activation of signaling events downstream of JNK/SAPK in these cells.
However, the induction of HMW-K by coexpression of catCLEF1 and
ΔMEKK1 is prevented by JNK inhibitor in C57MG cells (Figure 5, Q
and R). These data suggest a crucial role of the JNK/SAPK pathway in
squamous metaplasia of the Wnt-induced malignancy.
Activation of JNK/SAPK and Wnt/β-Catenin in Human
Endometrial and Lung Cancers
Squamous metaplasia rarely develops in human breast cancers but
is often found in other types of tumors including endometrial and
lung cancers. Activation of Wnt/β-catenin signaling has been linked
in the development of these cancers [43–48]. Therefore, we tested if
our finding has a general implication in development of human can-
cers. We first screened samples of human endometrioid adenocarci-
noma with squamous metaplasia (Figure 6A), expressing HMW-K
(Figure 6B), for the activation of Wnt/β-catenin signaling. Immuno-
staining of β-catenin and its transcriptional target cyclin D1 was per-
formed to determine if the canonical Wnt pathway was stimulated.
We found a 100% correlation of nuclear accumulations of β-catenin
with cyclin D1 in tumors with SM (Figure 6, C and D; n = 8). Im-
portantly, PJNK, Pp38, PErk1/2, PJun63, and PJun73 were strongly
expressed only in the cells undergoing squamous differentiation (Fig-
ure 6, E–I ; n = 3). Activation of JNK/SAPK and p38 coincided with
the expression of the squamous cell marker HMW-K (Figure 6B; n =
3). No expression of these proteins was detected in AC (n = 7; data
not shown). We next tested our hypothesis using human lung cancer
samples. Squamous cell carcinoma of the lung expressed high levels
of HMW-K (Figure 6, J and K ). The accumulation of β-catenin was
again correlated perfectly with the expression of cyclin D1 (Figure 6,
L and M ). High levels of PJNK, Pp38, PErk1/2, PJun63, and
PJun73 were also observed in the malignant squamous cells (Figure 6,
N –R; n = 7). On the basis of these observations, it is possible that
stimulation of JNK/SAPK signaling might play a role in the Wnt-
mediated squamous neoplasm of human cancers.
Discussion
The present study shows that stress signaling is stimulated during
normal development as well as neoplastic transformation of the mam-
mary gland. The JNK/SAPK and p38 MAPK cascades are strongly
activated in the lobulo-alveolar cells during pregnancy-mediated mam-
mary development. This developmental process is highly dependent
on the canonical Wnt pathway as we and others demonstrated pre-
viously [12,17,18]. As an alternative pathway of Wnt, JNK/SAPK
might coordinate with the canonical pathway to modulate alveolar
morphogenesis. Whereas β-catenin signaling is known to expand the
cell population, a second pathway might be important for the dif-
ferentiation process. It has been well recognized that activation of
the canonical Wnt pathway is tightly associated with the malignant
squamous phenotype [10,13,39,49]. However, the molecular mecha-
nism underlying the squamous metaplasia mediated by high levels of
Wnt/β-catenin signaling remains elusive. We have identified JNK/
SAPK as a candidate pathway for the secondary signaling cascade
Figure 4. Stimulation of Wnt/β-catenin signaling has no direct ef-
fects on JNK/SAPK activation. (A) Expression of dnAxin or catCLEF1
stabilizes β-catenin and enhances the expression of its target cyclin
D1 but has no significant effects on JNK/SAPK signaling. Phosphor-
ylation of p38, JNK, and c-Jun at Ser63 and Ser73 is stimulated by a
constitutively active form of MEKK1 (ΔMEKK1). (B) Expression of
Wnt1 or stimulation of Wnt signaling by LiCl induces β-catenin
and p38 but not JNK, similar to the effect caused by dnAxin. Immu-
noblot analyses of a stabilized form β-catenin (sβcat), cycD1, PJNK,
Pp38, PJun63, and PJun73 were performed with lysates of 293T
cells transfectedwith an empty vector, a plasmid expressing dnAxin,
catCLEF1, or ΔMEKK1, or treated with LiCl. The expression of actin
was analyzed as a loading control.
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involved in squamous differentiation. In theWnt-induced tumorigen-
esis, JNK/SAPK signaling is silent in hyperplasia and adenocarcinoma
but is highly elevated in cells undergoing squamous differentiation.
Reconstitution of these molecular events by synergistic activation of
β-catenin and JNK/SAPK signaling promotes squamous differen-
tiation in C57MG mammary epithelial cells, suggesting a co-opted
role of the JNK/SAPK signaling cascade in Wnt-mediated onco-
genic transformation.
We have extended our findings into the biology of human cancers
by showing that coordinated stimulation of these two pathways is
correlated with development of the malignant squamous cell type
in human endometrial and lung cancers. In addition, the JNK/SAPK
signaling molecules may serve as biomarkers for identifying the ma-
lignant squamous cell types in human cancers. This is of important
clinical significance with the advancement in modern cancer therapy.
In the past, it was sufficient to divide human lung cancers into small
cell and non–small cell types with the latter comprised mostly of ad-
enocarcinoma and squamous carcinoma. That was the era when the
therapeutic choice for small cell carcinoma was chemoradiation,
whereas adenocarcinoma and squamous carcinoma were similarly
treated with surgery. A new angiogenesis inhibitor, Avastin, is ef-
fective only for adenocarcinoma of the lung but has the potential
Figure 5. Squamous cell differentiation is promoted by synergistic activation of Wnt/β-catenin and JNK/SAPK. Mammary epithelial cells
C57MG (A–E) andC57MGWnt1 (F–J), a derivative of C57MGconstitutively expressingWnt1,were immunochemically stainedwith specific
antibodies for the expression of PJun63 (A, F), PJun73 (B, G), andHMW-K (E, J). The immunochemistry (brown)–stained cellswere counter-
stained with hematoxylin (blue). Immunostaining of C57MG and C57MGWnt1 cells with an antibody recognizing only activated β-catenin
(Act. β-cat; C, H) was counterstained by propidium iodide (D, I). Note that the C57MG cell line contains certain levels of JNK/SAPK activity,
leading to the phosphorylation of c-Jun at Ser63 and Ser73 (A–B and F–G). However, no squamous differentiation was evident because
HMW-K is negative (E). Constitutive expression of Wnt1 induced β-catenin signaling as it accumulated in the nucleus (H), which, together
with the existing JNK/SAPK signaling, promotes squamous differentiation (J). Synergistic activation of Wnt/β-catenin and JNK/SAPK sig-
naling by transient expression of a β-catenin-LEF1 fusion protein (catC-Lef1) and a dominant MEKK1 (ΔMEKK1), respectively, strongly
promotes squamous differentiation in mammary epithelial cells (N). The control transfected with vehicle only showed no expression of
squamous cell marker HMW-K (K). Expression of either ΔMEKK1 (L) or catC-Lef1 (M) slightly enhances the HMW-K expression. (O, P) The
presence of JNK inhibitor has no effect on the expression of HMW-K in C57MGWnt1 cells. In C57MG cells, the induction of HMW-K by
transfection of catC-Lef1 and ΔMEKK1 is prohibited by JNK inhibitor (Q, R). Scale bar, 100 μm (A–R).
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Figure 6. Co-opted JNK/SAPK signaling in the Wnt/β-catenin–mediated malignant transformation of human cancers. Sections of human
endometrial cancer exhibiting adenocarcinoma with squamous metaplasia (A–I) and human lung squamous cell carcinoma (J–R) were
analyzed by histologic diagnosis (A, J) and immunochemistry (B–I and K–R) for the expression of HMW-K (B, K), activated β-catenin (Act.
β-cat; C, L), cycD1 (D, M), PJun63 (E, N), PJun73 (F, O), PJNK (G, P), Pp38 (H, Q), and PErk1/2 (I, R). The immunochemistry (brown)–
stained sections were counterstained with hematoxylin (blue). Scale bars, 100 μm (A–R).
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to cause fetal pulmonary hemorrhage in patients with squamous cell
carcinoma. Since the advent of this drug, it has become critical
to separate these two tumor types. However, adenocarcinoma and
squamous cell carcinoma, sharing similar histologic features, can be
difficult to distinguish when they are poorly differentiated. It would
be interesting to determine whether the JNK/SAPK signaling mole-
cules can be used as additional markers for differential diagnosis. The
study may also shed light on the molecular pathogenesis of these two
tumor types in lung.
A previous report indicated that Wnt5a up-regulated in human
oral cancers is a potential marker of the malignant phenotype of
squamous cell carcinoma [50]. Because Wnt5a is a member of non-
canonical Wnt, the data support the notion of co-opted JNK/SAPK
signaling in Wnt-induced tumorigenesis. Activation of the JNK/
SAPK pathway was shown to mediate the expression of a squamous
cell marker SPRR1B in respiratory injuries caused by environmental
pollutants [51,52]. In a rat model of tobacco smoke–induced cell
proliferation and squamous metaplasia, the JNK/SAPK signaling
cascade and cyclin D1 expression were also stimulated [53]. Indeed,
Wnt/β-catenin signaling was shown to be activated in cigarette
smoke–induced lung tumorigenesis, further supporting our hypoth-
esis [54]. In addition, targeted disruption of Wnt7b in mice caused
lung hypoplasia due to defects in mesenchymal proliferation [55].
Wnt/β-catenin signaling is also required for branching morphogene-
sis and cell type specification of embryonic lung development [56–
58]. It has been suggested that Wnt/JNK signaling could diverge
from the canonical pathway at the level of Axin, which binds to
MEKK1 directly [23]. However, we failed to detect stimulation of
PJNK, PJun63, and PJun73 by Axin or dnAxin that contains all
the necessary domains required to activate JNK/SAPK as reported
previously [23]. Recent reports showed that ectopic expression of
Axin1 modulates the JNK/SAPK activity affecting embryonic dorso-
ventral patterning [59] and that the Axin-dependent JNK/SAPK ac-
tivation might contribute to the dominant-negative phenotypes of
the AxinFu allele [60]. Nevertheless, there is still a lack of in vivo ev-
idence to support the notion that Axin is essential for JNK/SAPK
activation. We also did not find any alterations of the JNK/SAPK
pathway in the Axin2-null mutants during skull morphogenesis (Liu
and Hsu, unpublished observations). Whether the loss of JNK/SAPK
activation contributed to the phenotypic defects caused by the disrup-
tion of Axin1 [40] or Axin2 [33] remains obscure. The present study
suggests that a stress-activated pathway parallel to Wnt/β-catenin is
necessary for the stimulation of JNK/SAPK signaling in squamous
metaplasia. However, we are not able to rule out the possibility that
this signaling converged at some point with the Wnt pathway, or
modulated its signaling, to induce squamous differentiation. The sig-
naling event might be modulated at the level upstream of Axin, e.g.,
Dsh/Dvl [25,61]. Diversin, shown to function as a molecular switch
to suppress Wnt/β-catenin while promoting Wnt/JNK, is another
candidate [62]. Future investigation focusing on the cooperation of
the Wnt/β-catenin and Wnt/JNK signaling cascades promises impor-
tant insight into the mechanism underlying normal development and
pathogenesis of human diseases.
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